The mechanism of action of ketamine upon ABA and other animal models of mental illness remains to be elucidated (Zorumski et al., 2016), but initial observations indicate the involvement of drebrin A, an F-actin binding protein enriched at excitatory synapses (Aoki et al., 2005). Here, DBN1 is linked to psychiatric disorder.